Tesamorelin

Tesamorelin is a synthetic form of growth-hormone-releasing hormone which is used in the treatment of HIV-associated lipodystrophy, approved initially in 2010.

Online Inquiry

Specification Technical Data Related Products Featured Products Customer reviews and Q&A Useful Tools Publications

CAT#	HB00122
CAS	218949-48-5 / 901758-09-6
Synonyms/Alias	Tesamorelin
M.F/Formula	C211H366N72O67S1
M.W/Mr.	5135.89
Sequence	Three Letter Code: Asp-Arg-Val-Tyr-Val-His-Pro-Phe
Biological Activity	Tesamorelin is a synthetic growth hormone releasing hormone analogue used in the treatment of visceral adiposity in human immunodeficiency virus (HIV) infected patients with lipodystrophy.

CAT#	Product Name	Inquiry
10-101-91	Neuropeptide Y (human, rat) Acetate	Inquiry
10-101-275	2-(2-(2-aminoethoxy)ethoxy)acetic acid AEEA	Inquiry
10-101-65	Obestatin (human)	Inquiry
10-101-10	Deslorelin Acetate	Inquiry
10-101-268	Arg-Gly-Asp (TFA salt)	Inquiry

CAT#	Product Name	M.W	Molecular Formula	Inquiry
10-101-20	Goserelin Acetate	1269.43	C59H84N18O14	Inquiry
10-101-59	Liraglutide	3751.2	C172H265N43O51	Inquiry
R1574	Octreotide	1019.24	C₄₉H₆₆N₁₀O₁₀S₂	Inquiry
10-101-139	Myrcludex B			Inquiry
10-101-285	Teduglutide	3752.08	C164H252N44O55S	Inquiry
R1847	Sermaglutide	4114	C187H291N45O59	Inquiry
R1961	Carbetocin	988.2	C45H69N11O12S	Inquiry

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Storage	Desiccate at -20°C
Shipping Condition	Room temperature in continental US; may vary elsewhere.